Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
GLP-1 Key Research Facts Full name: Glucagon-Like Peptide-1 incretin hormone of the proglucagon family Primary bioactive form: GLP-1(736)amide 30 amino acids, C-terminally amidated Gene source: Proglucagon gene processed by PCSK1 in intestinal L-cells and brainstem NTS neurons In vivo half-life: Approximately 12 minutes rapidly inactivated by DPP-4 (cleaves His7-Ala8 dipeptide) Primary receptor: GLP-1R (GLP-1 receptor) class B G protein-coupled receptor (GPCR) Signalling: GLP-1R activation cAMP elevation PKA/CREB activation glucose-dependent insulin secretion Additional signalling: PI3K/Akt pathway -cell survival, proliferation, and glucose sensitivity Secretion pattern: Biphasic post-meal release from intestinal L-cells early neural/endocrine peak + late direct nutrient-contact peak Fasting plasma level: ~510 pmol/L
Terushkin Dr
Cellular plasticity As one of the complications ahead of tumor therapy, turmeric cells' plasticity is defined as their ability to swing between asymmetric division and symmetric division, CSCs and non-CSCs, quiescence, and proliferation [180, 181]
However, prior to Pfizer's announcement of PF-06882961, scientists from Monash University in Australia and researchers from Novo Nordisk took the lead in publishing the high-resolution cryo-EM complex structures of the GLP-1 peptide, PF-06882961, and CHU-128 with the GLP-1R receptor in the journal Molecular Cell
US$ 29.89
US$ 27.54
US$ 28.33
US$ 21.74
US$ 26.70
